Stock Analysts’ Upgrades for March, 20th (ACOR, ALK, AMGN, ARII, BIIB, CF, CIR, COL, CRM, CTL)

Stock Analysts’ upgrades for Monday, March 20th:

Acorda Therapeutics (NASDAQ:ACOR) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. The firm currently has $30.58 target price on the stock.

Alaska Air Group (NYSE:ALK) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating.

Amgen (NASDAQ:AMGN) was upgraded by analysts at Vetr from a sell rating to a hold rating. They currently have $174.10 price target on the stock.

American Railcar Industries (NASDAQ:ARII) was upgraded by analysts at Cowen and Company from a market perform rating to an outperform rating. Cowen and Company currently has $45.00 target price on the stock.

Biogen (NASDAQ:BIIB) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. They currently have $310.17 target price on the stock.

CF Industries Holdings (NYSE:CF) was upgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a buy rating.

Circassia Pharmaceuticals PLC (LON:CIR) was upgraded by analysts at Stifel Nicolaus to a buy rating. Stifel Nicolaus currently has GBX 150 ($1.83) price target on the stock, up from their previous price target of GBX 99 ($1.21).

Rockwell Collins (NYSE:COL) was upgraded by analysts at Credit Suisse Group AG from a neutral rating to an outperform rating.

salesforce.com, inc. (NYSE:CRM) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. Vetr currently has $93.31 target price on the stock.

Centurylink (NYSE:CTL) was upgraded by analysts at Vetr from a hold rating to a buy rating. Vetr currently has $24.40 price target on the stock.

Delta Air Lines (NYSE:DAL) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. The firm currently has $52.43 target price on the stock.

Editas Medicine (NASDAQ:EDIT) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. Vetr currently has $27.14 price target on the stock.

FireEye (NASDAQ:FEYE) was upgraded by analysts at Bank of America Corp to a buy rating.

First Solar (NASDAQ:FSLR) was upgraded by analysts at Vetr from a hold rating to a buy rating. The firm currently has $33.19 price target on the stock.

Welltower (NYSE:HCN) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating.

HCP (NYSE:HCP) was upgraded by analysts at Morgan Stanley from an underweight rating to an equal weight rating.

Illumina (NASDAQ:ILMN) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. The firm currently has $187.82 target price on the stock.

Illumina (NASDAQ:ILMN) was upgraded by analysts at Leerink Swann from a market perform rating to an outperform rating.

Ingersoll-Rand PLC (NYSE:IR) was upgraded by analysts at Wells Fargo & Co from a market perform rating to an outperform rating.

Kinder Morgan (NYSE:KMI) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. They currently have $23.88 price target on the stock.

Shake Shack (NYSE:SHAK) was upgraded by analysts at Wedbush from an underperform rating to a neutral rating. They currently have $33.00 target price on the stock, up from their previous target price of $30.00.

Snap (NYSE:SNAP) was upgraded by analysts at Vetr from a hold rating to a buy rating. Vetr currently has $20.33 target price on the stock.

Sprague Resources (NYSE:SRLP) was upgraded by analysts at Janney Montgomery Scott from a neutral rating to a buy rating.

Sarepta Therapeutics (NASDAQ:SRPT) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. They currently have $34.53 target price on the stock.

3SBio (NASDAQ:SSRX) was upgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a buy rating.

Skyworks Solutions (NASDAQ:SWKS) was upgraded by analysts at Vetr from a sell rating to a hold rating. They currently have $95.08 price target on the stock.

Tiffany & Co. (NYSE:TIF) was upgraded by analysts at William Blair from a market perform rating to an outperform rating.

Time (NYSE:TIME) was upgraded by analysts at Stephens from an underweight rating to an equal weight rating.

CVR Partners (NYSE:UAN) was upgraded by analysts at Goldman Sachs Group Inc from a neutral rating to a buy rating.

Weatherford International Plc (NYSE:WFT) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. Vetr currently has $7.02 price target on the stock.

United States Steel (NYSE:X) was upgraded by analysts at Vetr from a strong sell rating to a hold rating. The firm currently has $36.38 target price on the stock.

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/stock-analysts-upgrades-for-march-20th-acor-alk-amgn-arii-biib-cf-cir-col-crm-ctl/1708695.html

Receive News & Ratings for Acorda Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acorda Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *